BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang DL, Gu DY, Huang HY, Xu Z, Chen JF. Irinotecan-involved regimens for advanced gastric cancer: A pooled-analysis of clinical trials. World J Gastroenterol 2010; 16(46): 5889-5894 [PMID: 21155012 DOI: 10.3748/wjg.v16.i46.5889]
URL: https://www.wjgnet.com/1007-9327/full/v16/i46/5889.htm
Number Citing Articles
1
Koji Tanaka, Takeshi Omori, Toshiro Nishida. Materia Medica for Various CancersEvidence-based Anticancer Complementary and Alternative Medicine 2012; 2: 69 doi: 10.1007/978-94-007-1983-5_4
2
Ahmet Tunceroglu, Salma K Jabbour. Gastric cancer: past accomplishments, present approaches and future aspirationsClinical Practice 2013; 10(1): 47 doi: 10.2217/cpr.12.82
3
Emil ter Veer, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven. The Use of (Network) Meta-Analysis in Clinical OncologyFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00822
4
Wei-Xiang Qi, Zan Shen, Feng Lin, Yuan-Jue Sun, Da-Liu Min, Li-Na Tang, Ai-Na He, Yang Yao. Overall survival benefits for irinotecan-containing regimens as first-line treatment for advanced gastric cancer: An updated meta-analysis of ten randomized controlled trialsInternational Journal of Cancer 2013; 132(2): E66 doi: 10.1002/ijc.27775
5
Xiaolong Qi, Yanna Liu, Wei Wang, Danxian Cai, Wende Li, Jialiang Hui, Chuan Liu, Yanxia Zhao, Guoxin Li. Management of advanced gastric cancer: An overview of major findings from meta-analysisOncotarget 2016; 7(47): 78180 doi: 10.18632/oncotarget.12102
6
Mohamed Mesmoudi, Tarik Mahfoud, Samir Ahid, Nabil Ismaili, Saber Boutayeb, Hassan Errihani. Three Weekly Irinotecan and Bolus 5-Fluorouracil Combination in the First Line Treatment of Advanced Gastric Cancer - A Single Institution ExperienceInternational Journal of Medicine and Surgery 2016; 3(1): 19 doi: 10.15342/ijms.v3i1.95
7
Jan Bornschein, Theodore Rokkas, Michael Selgrad, Peter Malfertheiner. Gastric Cancer: Clinical Aspects, Epidemiology and Molecular BackgroundHelicobacter 2011; 16: 45 doi: 10.1111/j.1523-5378.2011.00880.x
8
Rosine Guimbaud, Christophe Louvet, Pauline Ries, Marc Ychou, Emilie Maillard, Thierry André, Jean-Marc Gornet, Thomas Aparicio, Suzanne Nguyen, Ahmed Azzedine, Pierre-Luc Etienne, Eveline Boucher, Christine Rebischung, Pascal Hammel, Philippe Rougier, Laurent Bedenne, Olivier Bouché. Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) StudyJournal of Clinical Oncology 2014; 32(31): 3520 doi: 10.1200/JCO.2013.54.1011